David J. Lin, MD
Dr. David Lin is a Neurointensivist with additional subspecialization in Neurorehabilitation and Brain Injury Medicine. He is the Director of the Neurorecovery Clinic at Massachusetts General Hospital, in which patients with acute neurologic injuries receive comprehensive, neurorecovery-focused care throughout the post-acute care continuum. The overarching goal of Dr. Lin's research is to understand mechanisms of neural repair in order to guide recovery for patients after stroke and other acute brain injuries.
Our multidisciplinary group of MGH and IHP neurologists, occupational/physical/and speech therapists, physiatrists, neuroengineers, and neuroscientists are focused together on (1) collecting and analyzing rehabilitation outcome measures for patients recovering from stroke and (2) engineering and deploying neurotechnology (transcranial magnetic stimulation, brain computer interfaces) to characterize and maximize neurorecovery.
Stanford University, 2006: Mathematics and Computational Sciences
Harvard Medical School, 2013: Harvard/MIT Health Sciences and Technology Division
Massachusetts General Hospital, 2014: Medicine Internship
Massachusetts General Hospital/Brigham and Women's Hospital, 2017: Neurology Residency
Massachusetts General Hospital/Spaulding Rehabilitation Hospital 2018: Neurorecovery Fellowship
Massachusetts General Hospital/Brigham and Women's Hospital, 2020: Neurocritical Care Fellowship
Lin DJ, Cloutier AM, Erler KS, Cassidy JM, Snider SB, Ranford J, Parlman K, Giatsidis F, Burke JF, Schwamm LH, Finklestein SP, Hochberg LR, Cramer SC. Corticospinal Tract Injury Estimated From Acute Stroke Imaging Predicts Upper Extremity Motor Recovery After Stroke. Stroke. 2019:STROKEAHA119025898. Epub 2019/10/28. doi: 10.1161/STROKEAHA.119.025898. PubMed PMID: 31648631.
Bonin Pinto C, Morales-Quezada L, de Toledo Piza PV, Zeng D, Saleh Velez FG, Ferreira IS, Lucena PH, Duarte D, Lopes F, El-Hagrassy MM, Rizzo LV, Camargo EC, Lin DJ, Mazwi N, Wang QM, Black-Schaffer R, Fregni F. Combining Fluoxetine and rTMS in Poststroke Motor Recovery: A Placebo-Controlled Double-Blind Randomized Phase 2 Clinical Trial. Neurorehabil Neural Repair. 2019;33(8):643-55. Epub 2019/07/10. doi: 10.1177/1545968319860483. PubMed PMID: 31286828; PMCID: PMC6688938.
Lin DJ, Finklestein SP, Cramer SC. New Directions in Treatments Targeting Stroke Recovery. Stroke. 2018;49(12):3107-14. doi: 10.1161/STROKEAHA.118.021359. PubMed PMID: 30571435; PMCID: PMC6309806.